Heart transplantation in neonatal Marfan syndrome: Saving life in a rare and fatal condition

Neonatal Marfan syndrome is a rare disease with mortality in the first year of life reported as high as 95% predominantly due to progressive heart failure from valvar regurgitation and cardiomyopathy. Multisystem involvement and uncertain prognosis have historically precluded transplant candidacy, and current management options are of limited success.

[1]  A. Barnes,et al.  Cardiac allograft vasculopathy in pediatric heart transplant recipients does early-onset portend a worse prognosis? , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  R. Hetzer,et al.  Cardiomyopathy in Marfan syndrome. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  J. Towbin,et al.  The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary. [Corrected]. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  W. Gersony,et al.  Quadrivalvar Replacement in Infantile Marfan Syndrome , 2007, Pediatric Cardiology.

[5]  H. Dietz,et al.  Marfan syndrome: from molecular pathogenesis to clinical treatment. , 2007, Current opinion in genetics & development.

[6]  R. Hetzer,et al.  Orthotopic heart transplantation in patients with Marfan syndrome. , 2007, The Annals of thoracic surgery.

[7]  H. Scheld,et al.  Cardiac transplantation in neonatal Marfan syndrome -- a life-saving approach. , 2005, The Thoracic and cardiovascular surgeon.

[8]  H P Schultheiss,et al.  Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. , 1999, Circulation.

[9]  J. Rosenbloom,et al.  Extracellular matrix 4: The elastic fiber , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  R. Lacro,et al.  Recent Clinical Drug Trials Evidence in Marfan Syndrome and Clinical Implications. , 2016, The Canadian journal of cardiology.

[11]  V. Bhat.  Neonatal Marfan syndrome-A case report , 2015 .

[12]  J. L. Yntema,et al.  Neonatal Marfan syndrome : a case report , 1996 .

[13]  Y. Mahomed,et al.  Heart transplantation in patients with Marfan's syndrome: a survey of attitudes and results. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.